All News

When I told my friends and family I have multiple myeloma, some of them didn't know what to do.

For patients with non-small lung cancer and brain metastases, it’s important to consent to shaving the scalp before tumor-treating fields therapy.

New drug combinations and sequences are being investigated and may improve outcomes for patients with newly diagnosed myeloma, an expert explained at the Educated Patient® Multiple Myeloma Summit.

When my sister experienced nausea and vomiting during her Hodgkin lymphoma treatment, we tried alternatives that seemed to help.

The Food and Drug Administration will speed up their review and potential approval of Tagrisso for certain patients with EGFR-mutant lung cancer.

In this poem, a woman with liposarcoma writes about her feelings during a long hospital stay.

Data from the MajesTEC-1 trial shows that patients with relapsed/refractory multiple myeloma responded to Tecvalyi for a median of two years and lived without disease progression for nearly a year.

As part of the “Speaking Out” series, a radiation oncologist discusses the benefits of MRI-guided stereotactic body radiation therapy.

A Lynch syndrome diagnosis shook my world. Here is what I wish I was told from the get-go.

Through it all, poetry was the lens through which I could examine and deal with these very emotional and painful times in my life.

Seeing a young man ringing the bell surrounded by family reminded me of the incredible support I received during ovarian cancer, too.

On the harder days with my husband’s cancer, we would try to remember happy memories to help improve our moods.

Sarclisa, Velcade, Revlimid and dexamethasone improved progression-free survival in patients with multiple myeloma who were not eligible for transplant.

Patients with resectable stage 3 melanoma should talk about pretreatment therapy with their cancer care teams, an expert said.

Padcev and Keytruda improve survival and progression among patients with bladder cancer, but don’t adversely impact pain, functioning or quality of life.

It’s important for cancer survivors to follow-up with things that worry them. For me, my lymphedema sparked some fear.

From the NBA’s Alonzo Mourning opening up about his prostate surgery to an actor from “Felicity” dying of cancer, here’s what is happening in the oncology space this week.

The Food and Drug Administration has approved Rytelo to treat certain patients with low- to intermediate-1 risk MDS with transfusion-dependent anemia.

Trodelvy led to better disease control and improved quality of life compared to chemotherapy in patients with triple-negative breast cancer.

Keytruda plus platinum-based chemotherapy appeared to be safe and effective in treating penile squamous cell carcinoma.

When I came across an article with advice written by an oncologist for patients, I thought about his advice carefully.

For patients with cisplatin-ineligible bladder cancer, presurgical Padcev decreased the cancer stage without leading to delays in surgery.

Even though I will never be cancer-free from cholangiocarcinoma, I’m ready to face the next chapter in my life and make the most of it.

While the FDA approval of Truseltiq for FGFR2-positive cholangiocarcinoma was withdrawn, there are still other viable treatment options, an expert said.

Having a support system of loved ones truly helps during cancer.

After a cancer diagnosis, toxic positivity can be unhelpful, though forced joy may bring light to a difficult situation, a survivor and advocate said.

Learning that I had cancer — melanoma and renal cell carcinoma — made me feel like I lost something, but I keep looking ahead.

Some patients with stage 3 non-small cell lung cancer saw benefits from Opdivo plus chemotherapy followed by surgery then Opdivo, researchers found.